LXEO filings
Corporate insider profile
Richard Nolan Townsend Filing Activity
Latest reported as Chief Executive Officer of Lexeo Therapeutics, Inc. (LXEO).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$16,926.90
- Latest transaction
- May 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
